NCT07241988

Brief Summary

This randomized controlled study aims to examine the effects of using virtual reality glasses and white noise during peripheral intravenous catheterization on pain, anxiety, and satisfaction in adult patients. Participants will be randomly assigned to one of three groups: virtual reality, white noise, or control. Pain and anxiety levels will be assessed using standardized scales immediately after the procedure, and satisfaction will be evaluated following the intervention. The study aims to determine whether these non-pharmacological methods can reduce pain and anxiety and increase patient satisfaction during intravenous catheterization.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
76

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 11, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 17, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 21, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2026

Completed
Last Updated

March 24, 2026

Status Verified

March 1, 2026

Enrollment Period

4 months

First QC Date

November 17, 2025

Last Update Submit

March 21, 2026

Conditions

Keywords

Virtual RealityWhite NoiseIntravenous CatheterizationPainAnxiety

Outcome Measures

Primary Outcomes (1)

  • ain intensity during peripheral intravenous catheterization

    Pain intensity will be measured using a Visual Analogue Scale (VAS) ranging from 0 (no pain) to 10 (worst possible pain) immediately after the procedure.

    Immediately after peripheral intravenous catheterization

Secondary Outcomes (2)

  • Anxiety level during peripheral intravenous catheterization

    Three minutes before and immediately after the peripheral intravenous catheterization

  • Patient satisfaction related to peripheral intravenous catheterization

    Three minutes before and immediately after the peripheral intravenous catheterization

Study Arms (3)

Virtual Reality Group

EXPERIMENTAL

Participants in this group will wear virtual reality glasses displaying relaxing nature scenes during peripheral intravenous catheterization. The intervention will begin three minute before the procedure and continue until catheter insertion is completed.

Behavioral: Virtual Reality Glasses

White Noise Group

EXPERIMENTAL

Participants in this group will listen to natural white noise (the sound of rain) through headphones during peripheral intravenous catheterization. The sound will begin three minutes before the procedure and continue until the catheterization is completed.

Behavioral: White Noise (Rain Sound)

Control Group

NO INTERVENTION

Participants in this group will receive routine peripheral intravenous catheterization without any additional intervention.

Interventions

Participants in this group will wear virtual reality glasses displaying calming nature scenes accompanied by ambient sounds during peripheral intravenous catheterization. The intervention will begin three minutes before the procedure and continue until completion. This visual distraction technique is intended to reduce pain perception and anxiety levels and to increase patient satisfaction during the procedure.

Also known as: VR Glasses
Virtual Reality Group

Participants will listen to natural white noise, specifically the sound of rain, through headphones during peripheral intravenous catheterization. The sound will begin three minutes before the procedure and continue until completion. This auditory distraction technique is intended to reduce pain perception and anxiety levels and to increase patient satisfaction during the procedure.

White Noise Group

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • No verbal, visual, auditory, or perceptual communication impairment
  • Voluntary participation in the study
  • Clinical requirement for peripheral intravenous catheterization
  • No use of analgesic medication within the last 24 hours
  • No diagnosed neurological or psychiatric disorder
  • Ability to speak and understand Turkish
  • Successful peripheral intravenous catheterization on the first attempt

You may not qualify if:

  • Under 18 years of age
  • Clinically unstable condition
  • Individuals with psychiatric, mental, visual, or hearing impairments that prevent effective communication
  • Individuals experiencing pain for any reason or using analgesic medication for pain management
  • Individuals using anxiolytic or sedative medications
  • Individuals who do not consent to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dokuz Eylul University Hospital

İzmir, Balıkesir, 10715, Turkey (Türkiye)

Location

MeSH Terms

Conditions

PainAnxiety DisordersPatient Satisfaction

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental DisordersTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant Professor of Nursing

Study Record Dates

First Submitted

November 17, 2025

First Posted

November 21, 2025

Study Start

October 11, 2025

Primary Completion

January 30, 2026

Study Completion

January 30, 2026

Last Updated

March 24, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) may be available from the principal investigator upon reasonable request.

Locations